Roche’s Xofluza proves non-inferior to Tamiflu in children with flu
July 3, 2019Research and Development Roche, Tamiflu, flu, pharma
Roche has unveiled new Phase 3 data indicating that Xofluza (baloxavir marboxil) was well-tolerated and of comparable efficacy to its …
US Government awarded new patent on preventative HIV drugs PrEP
July 3, 2019Research and Development, Sales and Marketing Gilead, HHS, government, pharma
The Department of Health and Human Services (HHS) has been awarded a new patent on drugs that prevent HIV. The …
Elizabeth Warren calls on former FDA commissioner Scott Gottlieb to resign from board of Pfizer
July 2, 2019Research and Development FDA, Pfizer, Scott Gottlieb, health, pharma, public health
Democrat Presidential candidate Elizabeth Warren has criticised Scott Gottlieb for joining Pfizer. In a letter to Gottlieb, Senator Warren …
Biogen unveils promising new data for Spinraza in pre-symptomatic infants with spinal muscular atrophy
July 2, 2019Manufacturing and Production, Research and Development Biogen, Spinraza, pharma, spinal muscular atrophy
Biogen has introduced new data on the efficacy of Spinraza in the treatment of pre-symptomatic infants in spinal muscular atrophy …
UK industry spend on R&D collaborations grows to £377.3 million
July 2, 2019Manufacturing and Production, Medical Communications, Research and Development ABPI, R&D, pharma
The Association of the British Pharmaceutical Indusxtry (ABPI) has unveiled new data showed that UK industry investment in R&D collaborations …
Roche’s Tecentriq scores CHMP recommendation in PD-L1+ metastatic triple-negative breast cancer
July 2, 2019Manufacturing and Production, Research and Development, Sales and Marketing Roche, breast cancer, pharma, tecentriq
Roche’s immunotherapy Tecentriq (atezolizumab) has been recommended by the EMA’s Committee for Medicinal Products for Human Use (CHMP) in combination …
Libtayo becomes first EU-approved therapy for advanced cutaneous squamous cell carcinoma
July 2, 2019Manufacturing and Production, Sales and Marketing Europe, Libtayo, Regeneron, Sanofi, carcinoma, pharma
The European Commission has revealed that it has decided to award approval, albeit conditionally, to Sanofi and Regeneron’s Libtayo (cemiplimab) …
Hospitals in Oxfordshire to test for susceptibility to dangers of chemotherapy
July 1, 2019Manufacturing and Production Cancer, Diagnostics, NHS, UK, breast, colon, oesophogus, pharma
Hospitals in Oxfordshire have introduced a genetic test which helps doctors predict the dangerous side effects of chemotherapy. In …
Living with mal de debarquement syndrome
July 1, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing patient experience, pharma, rare disease
Polly Moyer reflects on her experiences living with the rare condition mal de debarquement syndrome, and discusses how connecting with …
Janssen secures two positive CHMP opinions for Imbruvica label expansions
July 1, 2019Sales and Marketing CHMP, EMA, Europe, Janssen, imbruvica, pharma
Janssen’s Imbruvica (ibrutinib) has racked up two positive recommendations from the European Medicines Agency’s Committee for Medicinal Products for Human …
Novartis says it did not send substances for chemical weapons to Syria
July 1, 2019Sales and Marketing Brenntag, Novartis, Syria, chemical weapons, pharma, war
Swiss firm Novartis has said that it did not send chemicals that could be used to make chemical weapons to …
FDA greenlights Pfizer biosimilar version of Genentech’s Avastin
July 1, 2019Sales and Marketing Cancer, Genentech, Pfizer, pharma, pncology
Pfizer is celebrating the approval by the FDA of Zirabev, its biosimilar version of Genentech’s Avastin (bevacizumab), which is now …
Pfizer’s Revatio flops in Phase 3 trial
July 1, 2019Sales and Marketing
American multinational Pfizer has said that Revatio (Sildenafil Citrate) in combination with nitric oxide, has failed to meet its primary …
Medicines recalled after FMD alert
July 1, 2019Sales and Marketing FMD, MHRA, labels, pharma, recall, supply chain
The MHRA has warned patients that batches of drugs for Parkinson’s, epilepsy and blood clots have been taken out of …
Read the July/August edition of Pharmafocus online now!
June 28, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Orkambi, Trump, UK, brexit, generics, manufacturing compliance, pharma
The latest monthly edition of Pharmafocus, the July/August issue, is available to read for free online now!The UK remains split …
Top Ten most popular articles on Pharmafile.com this week
June 28, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Allergan, Bristol-Myers Squibb, China, GSK, Novartis, Takeda, brexit
This week was diverse as always in terms of news coming out of the pharma industry, but the biggest news …
ImmunoGen to axe 220 positions as part of new restructuring strategy
June 28, 2019Manufacturing and Production, Medical Communications Immunogen, pharma
ImmunoGen has announced that, following an in-depth operational review to “extend the company’s cash runway”, it will be implemented a …
Janssen’s Darzalex combo approved by FDA in transplant-ineligible multiple myeloma patients
June 28, 2019Medical Communications, Sales and Marketing Janssen, darzalex, mutiple myeloma, pharma
Janssen’s Darzalex (daratumumab) has secured FDA approval in combination with lenalidomide and dexamethasone for the treatment of newly diagnosed multiple …
Former FDA Commissioner Scott Gottlieb elected to Pfizer’s Board of Directors
June 28, 2019Medical Communications FDA, Pfizer, Scott Gottlieb, pharma
Dr Scott Gottlieb, who stepped down from his role as the 23rd Commissioner of the FDA earlier this year, has …
Healthcare communications: Time to think differently with patient centricity
June 27, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Spink, patient centricity, pharma
Patient centricity, derived from the NHS-driven thinking “no decision about me, without me”, has been adopted by pharma to understand …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
